Bausch & Lomb offshoot ISTA
Pharmaceuticals has agreed to
pay US$33.5m in settlement of
US Department of Justice claims
arising from its marketing of
Xibrom (bromfenac).The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 27 May 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 13
HIGH rates of unnecessary prescribing reported in the Australian Institute of Health and Welfare (AIHW) Australia’s Health 2018 report highlights the need for greater integration of pharmacists in medication management roles, the Pharmaceutical Society of Australia (PSA) believes.